| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/04/2010 | CN101791409A peptide vectors |
| 08/04/2010 | CN101284869B Antiviral polypeptides and use |
| 08/03/2010 | US7767800 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes |
| 08/03/2010 | US7767787 Substance for obtaining highly effective tumor medications as well as a process |
| 08/03/2010 | US7767786 Neural regeneration peptides and methods for their use in treatment of neural injury or degeneration |
| 08/03/2010 | US7767648 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery; contain cleavage sites specifically cleaved by prostate specific membrane antigen (PSMA); useful for substantially inhibiting the non-specific toxicity of a variety of therapeutic drugs |
| 08/03/2010 | CA2359776C Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 07/29/2010 | WO2010085100A2 Novel cellular transmembrane domain and intracellular transduction system containing the same |
| 07/29/2010 | WO2010085039A2 Noggin-derived peptide and use thereof |
| 07/29/2010 | WO2010084851A1 Peptide capable of binding to immunoglobulin |
| 07/29/2010 | WO2010083573A1 The treatment or prophylaxis of organ and tissue fibrosis via modulation of cell division autoantigen (cda1) |
| 07/29/2010 | WO2010047515A3 Bipodal peptide binder |
| 07/29/2010 | US20100190960 Methods and Compositions for Detection of Ehrlichia chaffeensis (p120) |
| 07/29/2010 | US20100190957 Specific therapy and medicament using integrin ligands for treating cancer |
| 07/29/2010 | US20100190721 Peptide whitening agents and cosmetic compositions comprising the same |
| 07/29/2010 | US20100190720 Compositions and Methods for Preventing or Treating Cancer |
| 07/29/2010 | US20100190719 Peptides as antimicrobial agents towards campylobacter spp |
| 07/29/2010 | US20100190710 Il-23 receptor antagonists and uses thereof |
| 07/29/2010 | US20100190703 Peptides specific for human blood outgrowth endothelial cells |
| 07/29/2010 | US20100190698 Neuroprotective peptide inhibitors of AP-1 signaling and uses therefor |
| 07/29/2010 | US20100190693 Method for screening compounds & uses therefor |
| 07/29/2010 | US20100190164 Diagnosis and monitoring of renal failure using peptide biomarkers |
| 07/29/2010 | US20100190163 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 07/29/2010 | US20100189776 Anti-androgen peptides and uses thereof in cancer therapy |
| 07/29/2010 | US20100189742 HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines |
| 07/29/2010 | US20100189727 Masking Ligands For Reversible Inhibition Of Multivalent Compounds |
| 07/29/2010 | US20100189658 Imaging probes |
| 07/29/2010 | US20100186633 Peptide-based diblock and triblock dispersants and diblock polymers |
| 07/28/2010 | EP2211176A2 Analyzing nerve cell damage |
| 07/28/2010 | EP2209797A2 Modification of intrinsically disordered sequences for preparing vaccines |
| 07/28/2010 | EP1397486B1 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 07/28/2010 | CN1651457B Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens |
| 07/28/2010 | CN101787073A Methods and compositions for the treatment of gastrointestinal disorders |
| 07/28/2010 | CN101787072A Specific binding agents of human angiopoietin-2 |
| 07/28/2010 | CN101787071A Purification method of vapreotide |
| 07/27/2010 | US7763711 Consisting of the amino acid sequence SVASTITGV, the peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases |
| 07/27/2010 | US7763705 Viral peptides for use in activating immune response to treat and prevent viral infection |
| 07/27/2010 | US7763443 Expression vector comprising nucleotide sequences coding green fluorescent protein for use as reporter molecule in gene expression analysis |
| 07/27/2010 | US7763256 Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation |
| 07/27/2010 | CA2462686C Fret protease assays for clostridial toxins |
| 07/27/2010 | CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/22/2010 | WO2010082019A1 Actagardine derivatives, and pharmaceutical use thereof |
| 07/22/2010 | WO2010082018A1 Deoxyactagardine derivatives |
| 07/22/2010 | WO2010081975A1 Polypeptides for specific targeting to otx2 target cells |
| 07/22/2010 | WO2010057882A3 Composition for producing anti-amyloid beta peptide antibodies with d-peptides |
| 07/22/2010 | WO2010033923A3 Genus-wide chlamydial peptide vaccine antigens |
| 07/22/2010 | WO2010018378A3 Vaccine comprising amb 1 a peptides for use in the treatment of ragweed allergy |
| 07/22/2010 | WO2009129311A3 Somatostatin receptor 2 antagonists |
| 07/22/2010 | WO2003099841A9 Peptides and the use thereof in darkening the skin |
| 07/22/2010 | US20100186112 Novel Environmental Stress Resistance Transcription Factor and Method For Enhancing Environmental Stress Resistance of Plants Using the Same |
| 07/22/2010 | US20100184950 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 07/22/2010 | US20100184948 Molecules for targeting compounds to various selected organs or tissues |
| 07/22/2010 | US20100184947 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 07/22/2010 | US20100184946 Preparation of Fine Particles |
| 07/22/2010 | US20100184705 Therapeutic Peptides and Vaccines |
| 07/22/2010 | US20100184704 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent |
| 07/22/2010 | US20100184703 Use of peptide derivatives for treating pathologies resulting from ischemia |
| 07/22/2010 | US20100184702 Selective High-Affinity Polydentate Ligands and Methods of Making Such |
| 07/22/2010 | US20100184701 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof |
| 07/22/2010 | US20100184700 Preprocalcitonin antigen t epitopes |
| 07/22/2010 | US20100184699 Peptide Derived From Prostate-Related Protein As Cancer Vaccine Candidate For Prostate Cancer Patient Who Is Positive For Hla-A3 Super-Type Allele Molecule |
| 07/22/2010 | US20100184697 Peptide-based stat inhibitor |
| 07/22/2010 | US20100184695 Vascular endothelial cell-binding peptide |
| 07/22/2010 | US20100184692 Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation |
| 07/22/2010 | US20100184684 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184683 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184681 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184663 Methods and Compositions Related to Inhibition of Viral Entry |
| 07/22/2010 | US20100184652 Peptide inhibitors of abl kinases |
| 07/22/2010 | US20100184649 Novel antibacterial agents for the treatment of gram positive infections |
| 07/22/2010 | US20100184646 Melanocortin receptor ligands modified with hydantoin |
| 07/22/2010 | US20100184645 Stitched polypeptides |
| 07/22/2010 | US20100184637 Pharmaceutical and/or cosmetic composition containing an active antioxydant principle and cell energy activator |
| 07/22/2010 | US20100184606 Methods For Selective Targeting |
| 07/22/2010 | US20100184597 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants |
| 07/22/2010 | US20100184211 Tumour-Associated Peptides that Bind to MHC Molecules |
| 07/22/2010 | US20100184191 Novel method for generation of rna virus |
| 07/22/2010 | US20100184098 Methods for measuring enzyme activity |
| 07/22/2010 | US20100183651 Broadly Representative Antigen Sequences and Method for Selection |
| 07/22/2010 | US20100183647 Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 07/22/2010 | US20100183644 Tumour-Associated Peptides that Bind to MHC Molecules |
| 07/22/2010 | US20100183642 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 07/22/2010 | US20100183590 LSA-5 liver stage and blood stage antigen of Plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 07/22/2010 | US20100183510 EphB RECEPTOR-BINDING PEPTIDES |
| 07/22/2010 | US20100181197 Isoelectric point markers |
| 07/22/2010 | CA2750005A1 Polypeptides for specific targeting to otx2 target cells |
| 07/22/2010 | CA2749278A1 Deoxyactagardine derivatives |
| 07/21/2010 | EP2207807A2 Molecules and methods for modulating complement component |
| 07/21/2010 | EP1797112B1 Inhibitors of hepatitits c virus |
| 07/21/2010 | EP1677813B1 Angiogenic peptides and uses thereof |
| 07/21/2010 | CN101784560A Blood coagulation factor inhibitors |
| 07/21/2010 | CN101781359A Novel antibacterial peptide and preparation method and application thereof |
| 07/21/2010 | CN101781358A Novel antibacterial peptide and preparation method and application thereof |
| 07/21/2010 | CN101781357A Polypeptide for detecting human cancer cells, and application thereof |
| 07/21/2010 | CN101781356A Arginine hybrid cell-penetrating peptide and application thereof |
| 07/20/2010 | US7759460 hair-binding peptide ; improved durability for long lasting effects and are easy and inexpensive to prepare |
| 07/20/2010 | US7759459 Drug screening; enzyme inhibitors; fluorphores attached to serine, threonine, or tyrosine terminals |
| 07/20/2010 | US7759314 Stabilizing collagen VI-deficient dystrophin-associated protein complexes (DAPCs) on the surface of a cell by contacting the cell with an effective amount of a biglycan therapeutic; treatment of muscular dystrophies |
| 07/20/2010 | US7759302 Peptidic sulfonamides |
| 07/20/2010 | US7758861 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |